OLN vs OLMA: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

OLMA has stronger fundamentals based on our AI analysis.

OLN
OLIN Corp
STRONG SELL
88%
Confidence
VS
OLMA
Olema Pharmaceuticals, Inc.
SELL
75%
Confidence

OLN vs OLMA Fundamental Comparison

Metric OLN OLMA
Revenue $6.8B N/A
Net Income $-101.1M $-162.5M
Net Margin -1.5% N/A
ROE -5.5% -33.9%
ROA -1.4% -30.5%
Current Ratio 1.21x 9.95x
Debt/Equity 1.55x 0.00x
EPS $-0.88 $-1.87

Green = Better metric | Red = Weaker metric

View Full OLN Analysis →
View Full OLMA Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

OLN vs AAPL OLMA vs MSFT OLN vs GOOGL OLMA vs AMZN

OLN vs OLMA: Frequently Asked Questions

Is OLN or OLMA a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), OLMA has stronger fundamentals. OLN is rated STRONG SELL (88% confidence) while OLMA is rated SELL (75% confidence). This is not investment advice.

How does OLN compare to OLMA fundamentally?

OLIN Corp has ROE of -5.5% vs Olema Pharmaceuticals, Inc.'s -33.9%. Net margins are -1.5% vs N/A respectively.

Which stock pays higher dividends, OLN or OLMA?

OLN has a dividend yield of N/A or no dividend while OLMA has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in OLN or OLMA for long term?

For long-term investing, consider that OLN has STRONG SELL rating with 88% confidence, while OLMA has SELL rating with 75% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about OLN vs OLMA?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For OLN vs OLMA, the AI consensus favors OLMA based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.